{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:37:23Z","timestamp":1784554643232,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81101932"],"award-info":[{"award-number":["81101932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972378"],"award-info":[{"award-number":["81972378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.arcmed.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T07:36:08Z","timestamp":1671089768000},"page":"45-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-2271","authenticated-orcid":false,"given":"Chengquan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2022.12.003_bib0001","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-20-0800","article-title":"ENSAT registry-based randomized clinical trials for adrenocortical carcinoma","volume":"184","author":"Crona","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0003","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0004","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imr.12533","article-title":"Ferroptosis: bug or feature?","volume":"277","author":"Dixon","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0007","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","article-title":"Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein","volume":"16","author":"Dai","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1784529","article-title":"Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data","volume":"9","author":"Tian","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40618-020-01306-5","article-title":"The role of immune checkpoint inhibitor therapy in advanced adrenocortical carcinoma revisited: review of literature","volume":"43","author":"Brabo","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0011","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/diagnostics11020219","article-title":"A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma","volume":"11","author":"Luo","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0012","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/jcmm.16368","article-title":"Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas","volume":"25","author":"Zheng","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0013","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.7150\/ijbs.45050","article-title":"A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma","volume":"16","author":"Liang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0014","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.568397","article-title":"Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma","volume":"12","author":"Shen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107789","article-title":"Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma","volume":"98","author":"He","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0021","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.18632\/aging.103598","article-title":"Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711776","article-title":"An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients","volume":"11","author":"Shao","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0023","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12964-020-00663-1","article-title":"The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma","volume":"18","author":"Tang","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0024","article-title":"A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.675555","article-title":"A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma","volume":"9","author":"Zheng","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0026","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/biomedicines9030304","article-title":"Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance","volume":"9","author":"Araujo-Castro","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0027","doi-asserted-by":"crossref","first-page":"602","DOI":"10.21037\/tcr-20-2744","article-title":"Prognostic and clinical significance of Solute Carrier Family 7 Member 1 in ovarian cancer","volume":"10","author":"Gong","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0028","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.18632\/aging.103553","article-title":"A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma","volume":"12","author":"Wu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0029","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2016.10.068","article-title":"FANCD2 protects against bone marrow injury from ferroptosis","volume":"480","author":"Song","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0031","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.3390\/cancers12092545","article-title":"FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression","volume":"12","author":"Lei","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.587436","article-title":"Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers","volume":"8","author":"Sun","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.arcmed.2022.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41556-022-00950-8","article-title":"Stalled replication fork protection limits cGAS-STING and P-body-dependent innate immune signalling","volume":"24","author":"Emam","year":"2022","journal-title":"Nat Cell Biol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:52:04Z","timestamp":1759261924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440922001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0188440922001771"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.12.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}